By this approach, we found that GSKJ4 treatment abrogated the expression of NOTCH3 and NOTCH1 at both gene and protein levels and reduced the transcription of Notch target gene DELTEX1 in T-ALL cells (Figures 4A,C). The gene discussed is NOTCH1; the disease is acute lymphoblastic leukemia.